Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ceritinibum - capsule - ceritinibum 150 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carboxymethylamylum natricum a corresp. natrium 1.98 mg, magnesii stearas, silica colloidalis anhydrica, kapselhülle: gelatina, e 171, e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ceritinibum - compresse rivestite con film - ceritinibum 150 mg, cellulosum microcristallinum, hydroxypropylcellulosum, povidonum k 30, carmellosum natricum conexum corresp. natrium 0.05 mg, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, macrogolum 4000, talcum, e 171, e 132, pro compresso obducto. - onkologikum - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - ceritinib - carcinoma, polmone non a piccole cellule - agenti antineoplastici - zykadia è indicato per il trattamento di pazienti adulti affetti da carcinoma polmonare non a piccole cellule (nsclc) avanzato con anaplastico, linfoma e chinasi (alk) precedentemente trattato con crizotinib.

Unione Europea - italiano - EMA (European Medicines Agency)

pfizer europe ma eeig - lorlatinib - carcinoma, polmone non a piccole cellule - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

Unione Europea - italiano - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - nirmatrelvirum, ritonavirum - compresse rivestite con film - a): nirmatrelvirum 150 mg, cellulosum microcristallinum, lactosum monohydricum 185 mg, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, Überzug: hypromellosum, e 171, macrogolum 400, e 172 (rubrum), pro compresso obducto corresp. natrium 0.99 mg. b): ritonavirum 100 mg, copovidonum, silica colloidalis anhydrica, sorbitani lauras, calcii hydrogenophosphas, natrii stearylis fumaras, Überzug: hypromellosum, e 171, macrogolum 400, macrogolum 3350, hydroxypropylcellulosum, talcum, silica colloidalis anhydrica, polysorbatum 80, pro compresso obducto, natrium 0.388 mg. - behandlung von covid-19 - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

astellas pharma s.p.a. - tacrolimus - tacrolimus

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

s.f. group s.r.l. - itraconazolo - itraconazolo

Unione Europea - italiano - EMA (European Medicines Agency)

idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - sleep initiation and maintenance disorders - psicolettici - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

idorsia pharmaceuticals ltd - daridorexantum - compresse rivestite con film - daridorexantum 25 mg ut daridorexanti hydrochloridum, mannitolum, cellulosum microcristallinum, povidonum k 30, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, cellulosum microcristallinum, glycerolum, talcum, e 171, e 172 (rubrum), e 172 (nigrum) pro compresso obducto corresp. natrium 0.655 mg. - insonnia - synthetika